美国法医学基因组学市场规模、份额和趋势分析报告：按产品、方法、应用和细分市场预测，2025 年至 2033 年

美国法医学基因组学市场规模与趋势

预计 2024 年美国法医学基因组学市场规模为 2.565 亿美元，到 2033 年将达到 9.41 亿美元，2025 年至 2033 年的复合年增长率为 15.65%。

这一增长得益于基因组技术的进步、法医学DNA分析在刑事调查中的应用日益广泛，以及政府对法医学研究和基础设施建设的投入不断增加。此外，执法和法律诉讼中对精准快速识别方法的需求日益增长，预计将在预测期内推动市场扩张。

犯罪率上升，调查复杂度增加

犯罪活动（尤其是暴力犯罪、性侵犯和凶杀案）的不断增加是推动法医学基因组学市场成长的主要因素之一。随着刑事案件数量和复杂性的增加，对能够提供准确可靠证据的先进工具的需求也日益增长。法医学基因组学使执法机构能够以高度详细的基因水平分析生物样本，与传统法医学方法相比，它在识别嫌疑人和分析受害者方面具有更高的准确性。

此外，随着悬案和未破案件的增多，执法机构正在利用最新的基因组技术重新审查已存檔的证据，从而取得突破性发现并最终解决案件。对加快调查速度的需求以及减少冤假错案的压力进一步凸显了法医学基因组学在现代刑事司法体系中的重要性。这些因素共同导致了美国各地对法医学应用中基因组解决方案的需求持续增长。

目录

第一章调查方法与范围

第二章执行摘要

第三章市场变数、趋势和范围

• 市场体系展望
  • 母市场展望
  • 相关/辅助市场展望
• 市场趋势与展望
• 市场动态
  • 市场驱动因素分析
  • 市场限制因素分析
• 产业分析工具
  • 依因素（政治/法律、经济/技术）进行 SWOT 分析
  • 波特五力分析

第四章美国法医学基因体学市场：产品业务分析

• 产品细分仪表板
• 美国法医学基因组学市场：产品差异分析
• 2021 年至 2033 年美国法医学基因体学市场规模及趋势分析（依产品）
• 分析器和序列器
• 软体
• 套件和耗材

第五章美国法医学基因体学市场：方法论业务分析

• 方法论细分仪表板
• 美国法医学基因体学市场：方法变异分析
• 美国法医学基因组学市场规模和趋势分析（按方法论），2021 年至 2033 年
• 毛细管电泳
• 下一代定序
• PCR扩增
• 其他的

第六章美国法医学基因体学市场：应用商业分析

• 应用程式细分仪表板
• 美国法医学基因体学市场：应用变异分析
• 美国法医学基因体学市场规模及应用趋势分析（2021-2033）
• 刑事测试
• 亲子鑑定和家庭检测
• 其他的

第七章 竞争态势

• 参与企业
• 战略地图
• 2024年企业市场分析
• 参与企业概况
  • Illumina, Inc.
  • Thermo Fisher Scientific, Inc.
  • Merck KGaA
  • Agilent Technologies
  • Promega Corporation
  • QIAGEN
  • Bio-Rad Laboratories
  • LGC Limited
  • Tri Tech Forensics
  • Verogen

U.S. Forensic Genomics Market Size & Trends:

The U.S. forensic genomics market size was estimated at USD 256.5 million in 2024 and is projected to reach USD 941.0 million by 2033, expanding at a CAGR of 15.65% from 2025 to 2033. This growth is driven by advancements in genomic technologies, increasing adoption of forensic DNA analysis in criminal investigations, and rising government funding for forensic research and infrastructure. Moreover, the growing need for accurate and rapid identification methods in law enforcement and legal proceedings will fuel market expansion throughout the forecast period.

Increasing Crime Rates and Complexity of Investigations

Rising incidence of criminal activity, particularly violent crimes, sexual assaults, and homicides, is one of the primary drivers of the growth in the forensic genomics market. As the volume and complexity of criminal cases increases, there is a greater need for advanced tools to provide accurate and reliable evidence. Forensic genomics enables law enforcement agencies to analyze biological samples at a highly detailed genetic level, offering superior accuracy in suspect identification and victim profiling compared to traditional forensic methods.

Moreover, the growing number of unresolved and cold cases has prompted agencies to revisit archived evidence using modern genomic techniques, leading to breakthroughs and case resolutions. The demand for rapid turnaround in investigations and pressure to minimize wrongful convictions further underscores the importance of forensic genomics in the modern criminal justice system. These factors collectively contribute to sustained and increasing demand for genomic solutions in forensic applications across the U.S.

U.S. Forensic Genomics Market Report Segmentation

This report forecasts revenue growth at the country level and provides an analysis on the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the U.S. forensic genomics market report based on product, method, and application:

• U.S. Forensic Genomics Product Outlook (Revenue, USD Million, 2021 - 2033)
• Analyzers & Sequencers
• Software
• Kits & Consumables
• U.S. Forensic Genomics Method Outlook (Revenue, USD Million, 2021 - 2033)
• Capillary Electrophoresis
• Next-generation Sequencing
• PCR Amplification
• Others
• U.S. Forensic Genomics Application Outlook (Revenue, USD Million, 2021 - 2033)
• Criminal Testing
• Paternity & Familial Testing
• Others

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Market Definitions
  • 1.2.1. Product Segment
  • 1.2.2. Method Segment
  • 1.2.3. Application Segment
• 1.3. Information Analysis
  • 1.3.1. Market Formulation & Data Visualization
• 1.4. Data Validation & Publishing
• 1.5. Information Procurement
  • 1.5.1. Primary Research
• 1.6. Information or Data Analysis
• 1.7. Market Formulation & Validation
• 1.8. Market Model
• 1.9. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/Ancillary Market Outlook
• 3.2. Market Trends and Outlook
• 3.3. Market Dynamics
  • 3.3.1. Market Driver Analysis
    • 3.3.1.1. Rising government funds and initiatives for forensic programs
    • 3.3.1.2. Increasing crime rates
    • 3.3.1.3. Technological advancements in paternity & familial testing
  • 3.3.2. Market Restraint Analysis
    • 3.3.2.1. High cost of equipment
• 3.4. Industry Analysis Tools
  • 3.4.1. SWOT Analysis; By Factor (Political & Legal, Economic And Technological)
  • 3.4.2. Porter's Five Forces Analysis

Chapter 4. U.S. Forensic Genomics Market: Product Business Analysis

• 4.1. Product Segment Dashboard
• 4.2. U.S. Forensic Genomics Market: Product Movement Analysis
• 4.3. U.S. Forensic Genomics Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Million)
• 4.4. Analyzers & Sequencers
  • 4.4.1. Analyzers & Sequencers Market, 2021 - 2033 (USD Million)
• 4.5. Software
  • 4.5.1. Software Market, 2021 - 2033 (USD Million)
• 4.6. Kits & Consumables
  • 4.6.1. Kits & Consumables Market, 2021 - 2033 (USD Million)

Chapter 5. U.S. Forensic Genomics Market: Method Business Analysis

• 5.1. Method Segment Dashboard
• 5.2. U.S. Forensic Genomics Market: Method Movement Analysis
• 5.3. U.S. Forensic Genomics Market Size & Trend Analysis, by Method, 2021 to 2033 (USD Million)
• 5.4. Capillary Electrophoresis
  • 5.4.1. Capillary Electrophoresis Market, 2021 - 2033 (USD Million)
• 5.5. Next-generation Sequencing
  • 5.5.1. Next-generation Sequencing Market, 2021 - 2033 (USD Million)
• 5.6. PCR Amplification
  • 5.6.1. PCR Amplification Market, 2021 - 2033 (USD Million)
• 5.7. Others
  • 5.7.1. Others Market, 2021 - 2033 (USD Million)

Chapter 6. U.S. Forensic Genomics Market: Application Business Analysis

• 6.1. Application Segment Dashboard
• 6.2. U.S. Forensic Genomics Market: Application Movement Analysis
• 6.3. U.S. Forensic Genomics Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
• 6.4. Criminal Testing
  • 6.4.1. Criminal Testing Market, 2021 - 2033 (USD Million)
• 6.5. Paternity & Familial Testing
  • 6.5.1. Paternity & Familial Testing Market, 2021 - 2033 (USD Million)
• 6.6. Others
  • 6.6.1. Others Market, 2021 - 2033 (USD Million)

Chapter 7. Competitive Landscape

• 7.1. Participant Categorization
• 7.2. Strategy Mapping
• 7.3. Company Market Position Analysis, 2024
• 7.4. Participant's Overview
  • 7.4.1. Illumina, Inc.
    • 7.4.1.1. Overview
    • 7.4.1.2. Financial Performance
    • 7.4.1.3. Product Benchmarking
    • 7.4.1.4. Strategic Initiatives
  • 7.4.2. Thermo Fisher Scientific, Inc.
    • 7.4.2.1. Overview
    • 7.4.2.2. Financial Performance
    • 7.4.2.3. Product Benchmarking
    • 7.4.2.4. Strategic Initiatives
  • 7.4.3. Merck KGaA
    • 7.4.3.1. Overview
    • 7.4.3.2. Financial Performance
    • 7.4.3.3. Product Benchmarking
    • 7.4.3.4. Strategic Initiatives
  • 7.4.4. Agilent Technologies
    • 7.4.4.1. Overview
    • 7.4.4.2. Financial Performance
    • 7.4.4.3. Product Benchmarking
    • 7.4.4.4. Strategic Initiatives
  • 7.4.5. Promega Corporation
    • 7.4.5.1. Overview
    • 7.4.5.2. Financial Performance
    • 7.4.5.3. Product Benchmarking
    • 7.4.5.4. Strategic Initiatives
  • 7.4.6. QIAGEN
    • 7.4.6.1. Overview
    • 7.4.6.2. Financial Performance
    • 7.4.6.3. Product Benchmarking
    • 7.4.6.4. Strategic Initiatives
  • 7.4.7. Bio-Rad Laboratories
    • 7.4.7.1. Overview
    • 7.4.7.2. Financial Performance
    • 7.4.7.3. Product Benchmarking
    • 7.4.7.4. Strategic Initiatives
  • 7.4.8. LGC Limited
    • 7.4.8.1. Overview
    • 7.4.8.2. Financial Performance
    • 7.4.8.3. Product Benchmarking
    • 7.4.8.4. Strategic Initiatives
  • 7.4.9. Tri Tech Forensics
    • 7.4.9.1. Overview
    • 7.4.9.2. Financial Performance
    • 7.4.9.3. Product Benchmarking
    • 7.4.9.4. Strategic Initiatives
  • 7.4.10. Verogen
    • 7.4.10.1. Overview
    • 7.4.10.2. Financial Performance
    • 7.4.10.3. Product Benchmarking
    • 7.4.10.4. Strategic Initiatives

List of Tables

• Table 1 List of Secondary Sources
• Table 2 List of Abbreviations
• Table 3 U.S. Forensic Genomics Market, by Product, 2021 - 2033 (USD Million)
• Table 4 U.S. Forensic Genomics Market, by Method, 2021 - 2033 (USD Million)
• Table 5 U.S. Forensic Genomics Market, by Application, 2021 - 2033 (USD Million)

List of Figures

• Fig. 1 U.S. forensic genomics market segmentation
• Fig. 2 Data analysis models
• Fig. 3 Market formulation and validation
• Fig. 4 Data validating & publishing
• Fig. 5 Market research process
• Fig. 6 Information procurement
• Fig. 7 Primary research
• Fig. 8 Value-chain-based sizing & forecasting
• Fig. 9 QFD modelling for market share assessment
• Fig. 10 Market formulation & validation
• Fig. 11 Commodity flow analysis
• Fig. 12 Market outlook
• Fig. 13 Segments snapshot
• Fig. 14 Competitive landscape snapshot
• Fig. 15 U.S. forensic genomics market value, 2024 (USD million)
• Fig. 16 Market trends & outlook
• Fig. 17 PESTEL analysis
• Fig. 18 Porter's five forces analysis
• Fig. 19 U.S. Forensic Genomics Market: Product Key Takeaways
• Fig. 20 U.S. Forensic Genomics Market: Product Movement Analysis
• Fig. 21 U.S. Forensic Genomics Market, for Analyzers & Sequencers, 2021 - 2033 (USD Million)
• Fig. 22 U.S. Forensic Genomics Market, for Software, 2021 - 2033 (USD Million)
• Fig. 23 U.S. Forensic Genomics Market, for Kits & Consumables, 2021 - 2033 (USD Million)
• Fig. 24 U.S. Forensic Genomics Market: Method Key Takeaways
• Fig. 25 U.S. Forensic Genomics Market: Method Movement Analysis
• Fig. 26 U.S. Forensic Genomics Market, for Capillary Electrophoresis, 2021 - 2033 (USD Million)
• Fig. 27 U.S. Forensic Genomics Market, for Next-generation Sequencing, 2021 - 2033 (USD Million)
• Fig. 28 U.S. Forensic Genomics Market, for PCR Amplification, 2021 - 2033 (USD Million)
• Fig. 29 U.S. Forensic Genomics Market, for Others, 2021 - 2033 (USD Million)
• Fig. 30 U.S. Forensic Genomics Market: Application Key Takeaways
• Fig. 31 U.S. Forensic Genomics Market, Application Movement Analysis
• Fig. 32 U.S. Forensic Genomics Market, for Criminal Testing, 2021 - 2033 (USD Million)
• Fig. 33 U.S. Forensic Genomics Market, for Paternity & Familial Testing, 2021 - 2033 (USD Million)
• Fig. 34 U.S. Forensic Genomics Market, for Others, 2021 - 2033 (USD Million)
• Fig. 35 Strategic framework